GOT2 and neoplasm: Downregulation of GLS, GOT2, and ASNS effectively blocks SOX12-mediated CRC cell proliferation and metastasis, while ectopic expression of these enzymes reverses the inhibitory effects of SOX12 knockdown on tumor progression (36).